Loading...
Neoadjuvant Therapy in Pancreatic Cancer: An Emerging Strategy
Pancreatic adenocarcinoma (PDAC) is the fourth leading cause of cancer deaths among men and women, being responsible for 6% of all cancer-related deaths. Surgical resection offers the only chance of cure, but only 15 to 20 percent of cases are potentially resectable at presentation. In recent years,...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Artigo |
Language: | Inglês |
Published: |
Hindawi Publishing Corporation
2014
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4101999/ https://ncbi.nlm.nih.gov/pubmed/25101123 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/183852 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|